Significant fibrosis, as measured by FibroScan, was independently linked to type 2 diabetes in patients with metabolic dysfunction-associated steatotic liver disease.
After a recent myocardial infarction, daily low-dose colchicine reduces the risk for cardiovascular events in patients with type 2 diabetes, a recent study shows.
New findings challenge the growing popularity of food-as-medicine programs by showing that one such program didn't improve glycemic control in individuals with high blood sugar.
People with diabetes who have a positive sense of humor appear to have better glucose control, indicates research suggesting humor training could be incorporated into patient management.